| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,085 |
10,371 |
$1.73M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,153 |
5,721 |
$1.07M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,432 |
1,342 |
$772K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,748 |
1,653 |
$539K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,402 |
2,247 |
$188K |
| 70450 |
Computed tomography, head or brain; without contrast material |
737 |
695 |
$105K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
67 |
65 |
$20K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
47 |
47 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
48 |
43 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,634 |
2,371 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,329 |
2,283 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
1,764 |
1,685 |
$355.91 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,089 |
5,554 |
$349.51 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,441 |
3,175 |
$321.15 |
| 81025 |
|
2,867 |
2,668 |
$316.30 |
| 87040 |
|
84 |
83 |
$215.17 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,400 |
1,341 |
$213.23 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,403 |
2,217 |
$202.72 |
| 71045 |
Radiologic examination, chest; single view |
2,500 |
2,388 |
$186.12 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,383 |
2,162 |
$183.40 |
| 80053 |
Comprehensive metabolic panel |
4,901 |
4,514 |
$143.92 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
235 |
222 |
$140.83 |
| 81003 |
|
4,969 |
4,578 |
$129.65 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,478 |
1,433 |
$78.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,289 |
3,013 |
$55.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,904 |
2,706 |
$52.24 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
136 |
131 |
$51.31 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,011 |
1,878 |
$48.00 |
| 85379 |
|
796 |
745 |
$42.06 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
194 |
174 |
$40.55 |
| 82803 |
|
1,003 |
938 |
$35.99 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
640 |
608 |
$29.51 |
| 83605 |
|
1,007 |
938 |
$27.91 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
578 |
518 |
$15.26 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
778 |
747 |
$14.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
332 |
316 |
$9.94 |
| 84484 |
|
1,718 |
1,578 |
$8.47 |
| 80051 |
|
1,215 |
1,135 |
$6.23 |
| 36415 |
Collection of venous blood by venipuncture |
5,956 |
5,429 |
$3.42 |
| 82150 |
|
796 |
728 |
$0.00 |
| J3490 |
Unclassified drugs |
1,284 |
1,146 |
$0.00 |
| 83880 |
|
151 |
145 |
$0.00 |
| 82962 |
|
86 |
80 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
461 |
401 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
55 |
55 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
41 |
41 |
$0.00 |
| 96376 |
|
45 |
38 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
56 |
46 |
$0.00 |
| 87077 |
|
28 |
28 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
26 |
24 |
$0.00 |
| 83690 |
|
19 |
19 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
19 |
19 |
$0.00 |
| 90715 |
|
53 |
53 |
$0.00 |
| 80076 |
|
787 |
718 |
$0.00 |
| 82977 |
|
797 |
728 |
$0.00 |
| 73630 |
|
131 |
124 |
$0.00 |
| 84702 |
|
659 |
616 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
220 |
212 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
25 |
24 |
$0.00 |
| 73130 |
|
71 |
67 |
$0.00 |
| 73610 |
|
71 |
69 |
$0.00 |
| 73110 |
|
14 |
13 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
55 |
55 |
$0.00 |
| 87186 |
|
25 |
25 |
$0.00 |
| 80305 |
|
25 |
25 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
83 |
79 |
$0.00 |